CARPETS
03 Dec 2020
CARPETS
ACTRN12613000198729
Study of increasing doses of genetically modified GD2-specific T cells in patients with metastatic melanoma and refractory solid tumours
CALHN
Cancer Type | Melanoma & other skin |
---|---|
Trial Type | Treatment |
Phase | Phase I |
Age Range | 18 years and older |
Sex | All |
Tumour Stream | - |
Cancer Stage | Metastatic or Widespread |
Anticipated Start Date | 2013-03-29 |
Anticipated End Date | - |
Hospital | Royal Adelaide Hospital |
---|---|
Clinical Trial Coordinator | Anne Milton |
anne.milton@sa.gov.au | |
Phone | 08 7074 2342 |
Principal Investigator | Professor Michael Brown |
Recruitment Status | Recruiting |
Hospital | Flinders Medical Centre |
---|---|
Clinical Trial Coordinator | Alex Scott-Hoy |
alex.scott-hoy@sa.gov.au | |
Phone | 08 8204 4830 |
Principal Investigator | - |
Recruitment Status | Recruiting |
Keep up to date with the latest news and breakthroughs